Synthesis and biological evaluation of novel propylamine derivatives as orally active squalene synthase inhibitors

被引：22

作者：

Ishihara, T ^{[1
]}

Kakuta, H ^{[1
]}

Moritani, H ^{[1
]}

Ugawa, T ^{[1
]}

Yanagisawa, I ^{[1
]}

机构：

[1] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Chem Labs, Tsukuba, Ibaraki 3058585, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2004年 / 12卷 / 22期

关键词：

squalene synthase; antihypercholesterolemic effect; antihypertriglyceridemic effect; hepatotoxicity;

D O I：

10.1016/j.bmc.2004.08.033

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Squalene synthase inhibitors are potentially superior hypolipidemic agents. We synthesized novel propylamine derivatives, as well as evaluated their ability to inhibit squalene synthase and their lipid-lowering effects in rats. 1-Allyl-2-[3-(benzylamino)propoxy]-9H-carbazole (YM-75440) demonstrated potent inhibition of the enzyme derived from HepG2 cells with an IC50 value of 63nM. It significantly reduced both plasma total cholesterol and plasma triglyceride levels following oral dosing to rats with a reduced tendency to elevate plasma transaminase levels. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：5899 / 5908

页数：10

共 50 条

[21] Synthesis of oxadiazoline and quinazolinone derivatives and their biological evaluation as nitric oxide synthase inhibitors
Jose Pineda de las Infantas, M.
Dora Carrion, M.
Chayah, Mariem
Lopez-Cara, Luisa C.
Gallo, Miguel A.
Acuna-Castroviejo, Dario
Encarnacion Camacho, M.
MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (06) : 1260 - 1273
[22] Synthesis of oxadiazoline and quinazolinone derivatives and their biological evaluation as nitric oxide synthase inhibitors
M. José Pineda de las Infantas
M. Dora Carrión
Mariem Chayah
Luisa C. López-Cara
Miguel A. Gallo
Darío Acuña-Castroviejo
M. Encarnación Camacho
Medicinal Chemistry Research, 2016, 25 : 1260 - 1273
[23] SYNTHESIS OF NOVEL MONOCYCLIC SQUALESTATIN ANALOGS AS POTENTIAL INHIBITORS OF SQUALENE SYNTHASE
SHAW, RE
BURGESS, C
COUSINS, RPC
GIBLIN, GMP
LIVERMORE, DGH
SHINGLER, AH
SMITH, C
YOUDS, PM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (18) : 2155 - 2160
[24] Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53-MDM2 Protein-Protein Interaction
Zhuang, Chunlin
Miao, Zhenyuan
Zhu, Lingjian
Dong, Guoqiang
Guo, Zizhao
Wang, Shengzheng
Zhang, Yongqiang
Wu, Yuelin
Yao, Jianzhong
Sheng, Chunquan
Zhang, Wannian
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9630 - 9642
[25] SQUALENE SYNTHASE INHIBITORS - SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF A SERIES OF SUBSTITUTED QUINUCLIDINES
SCOTESE, AC
NEUENSCHWANDER, K
AMIN, D
GUSTAFSON, S
NEEDLE, S
RUTLEDGE, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 95 - ORGN
[26] Synthesis and evaluation of aziridine analogues of presqualene diphosphate as squalene synthase inhibitors
Koohang, A
Coates, RH
Owen, D
Poulter, CD
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (01): : 6 - 7
[27] Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors
Wang, Yuanyuan
Ma, Hao
Huang, Jiaxuan
Yao, Zhengguang
Yu, Jianqiang
Zhang, Wannian
Zhang, Lichao
Wang, Zhibin
Zhuang, Chunlin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
[28] Design, synthesis and biological evaluation of novel spiro-quinazolinone derivatives as chitin synthase inhibitors and antifungal agents
Du, Chuanbiao
Yang, Xinlong
Long, Yan
Lang, Xueqing
Liu, Lige
Xu, Yajie
Wu, Hu
Chu, Yiwen
Hu, Xiaolei
Deng, Junfeng
Ji, Qinggang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 255
[29] Novel optimised quinuclidine squalene synthase inhibitors
Brown, GR
Foubister, AJ
Freeman, S
McTaggart, F
Mirrlees, DJ
Reid, AC
Smith, GJ
Taylor, MJ
Thomason, DA
Whittamore, PRO
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 597 - 600
[30] Design, synthesis, and evaluation of orally active fibrinogen inhibitors
Tanaka, A
Sakai, H
Ishikawa, T
Aoki, T
Moroyama, Y
Takasugi, H
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 521 - 526

← 1 2 3 4 5 →